Learn more

DEFENSIN THERAPEUTICS APS

Overview
  • Total Patents
    54
  • GoodIP Patent Rank
    28,409
  • Filing trend
    ⇩ 38.0%
About

DEFENSIN THERAPEUTICS APS has a total of 54 patent applications. It decreased the IP activity by 38.0%. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are EVANS-FREKE STEPHEN, ASCENDIS PHARMA OPHTHALMOLOGY DIVISION AS and ALFACYTE LTD.

Patent filings per year

Chart showing DEFENSIN THERAPEUTICS APSs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Nordkild Peter 37
#2 Kjaerulff Søren 14
#3 Wehkamp Jan 10
#4 Kjaerulff Soren 9
#5 Norkild Peter 6
#6 Peter Nordkild 5
#7 Andersen Birgitte 5
#8 Søren Kjærulff 4
#9 Brinch Karoline Sidelmann 3
#10 Kjarulff Soren 3

Latest patents

Publication Filing date Title
BR112020010180A2 B-DEFENSIN AND / OR A-HUMAN DEFENSIN FOR USE IN PREVENTING OR TREATING GRAFT DISEASE AGAINST ACUTE HOST
CN111556759A Maturation of mucosal defenses and intestinal/pulmonary function in premature infants
AU2017376400A1 Methods for treating inflammatory conditions of the lungs
KR20190003592A Treatment of liver, biliary and pancreatic disorders
RU2738265C2 Methods for modulating intestinal microbiota
EP2729159A2 Oral treatment of inflammatory bowel disease